Ekso Bionics (EKSO) Short Interest Ratio & Short Volume

Short interest is the volume of Ekso Bionics shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 190,300 shares of EKSO short. Learn More on Ekso Bionics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EKSO shares currently have a short interest ratio of 1.0. Learn More on Ekso Bionics's short interest ratio.

Ekso Bionics saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 190,300 shares, an increase of 41.7% from the previous total of 134,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies compare to Ekso Bionics: ZIVO Bioscience, Inc. (4.24%), Oncternal Therapeutics, Inc. (0.52%), Benitec Biopharma Inc. (0.50%), Evaxion Biotech A/S (0.92%), Lisata Therapeutics, Inc. (0.24%), Cumberland Pharmaceuticals Inc. (0.22%), TherapeuticsMD, Inc. (0.41%), Flora Growth Corp. (7.33%), Cue Health Inc. (0.52%), PolyPid Ltd. (0.15%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks.

Short selling EKSO is an investing strategy that aims to generate trading profit from Ekso Bionics as its price is falling. EKSO shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Ekso Bionics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EKSO, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EKSO, twice per month. The most recent reporting period available is April, 15 2024.